Altre lingue

03/12 Italy - Factors to watch on December 3
02/12 Ulisse Biomed shareholders approve name change to Helyx Industries
28/11 Ulisse Biomed capital hike subscribed for EUR592,500
25/11 Ulisse Biomed says it has received EUR 0.8 mln order, ups 2025 revenue guidance
21/11 Ulisse Biomed subscribes capital hike for EUR 0.5 mln
14/11 Ulisse Biomed board has approved capital hike for up to EUR 0.7 mln
08/10/25 Ulisse Biomed S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2025
30/09/25 Ulisse Biomed H1 net loss EUR 2.4 mln
31/07/25 Ulisse Biomed signed an investment agreement with U.S. investor Global Corporate Finance
31/03/25 Ulisse Biomed FY Net Loss EUR 5.9 Mln
28/03/25 Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2024
17/12/24 Ulisse Biomed S.p.A. announced that it expects to receive ?0.136493 million in funding
01/10/24 Ulisse Biomed S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2024
12/06/24 Ikonisys, Ulisse Biomed to Collaborate on New Cancer Diagnostic Technologies
12/06/24 Ikonisys S A : 'allie à Ulisse Biomed dans le diagnostic du cancer
20/05/24 Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023
15/01/24 Hyris Fulfils Its Integration into Ulisse Biomed to Give Birth to A New International Group
28/12/23 Ulisse Biomed S p A : NEW AGREEMENT BETWEEN HYRIS AND CREA FOR THE DEVELOPMENT OF AGRICULTURAL TESTING
05/12/23 Hyris Ltd. agreed to acquire Ulisse Biomed S.p.A. (BIT : UBM) on December 5, 2023.
10/11/23 Microbix Biosystems Inc. Announces Collaboration with Ulisse Biomed S.P.A
30/09/23 Ulisse Biomed S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023
28/03/23 Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022
31/10/22 “Warrant Ulisse Biomed S.p.A. 2021-2026”: risultati del secondo periodo di esercizio
30/09/22 Ulisse Biomed S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2022
30/06/22 “Warrant Ulisse Biomed S.p.A. 2021-2026”: risultati del primo periodo di esercizio
Non ci sono risultati per questa ricerca